Source: Appen
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Appen (ASX:APX) appoints Ryan Kolln as its new CEO and Managing Director
  • Mr Kolln brings an extensive understanding of Appen’s business and the AI industry to the role
  • His journey within Appen saw him take on the role of COO in 2023, where he oversaw global operations and strategy
  • Mr Kolln will be based in North America
  • APX shares are down 1.79 per cent, trading at 27.5 cents at 1:51 pm AEDT

Appen (ASX:APX) has announced the immediate appointment of Ryan Kolln as its new CEO and Managing Director, succeeding Armughan Ahmad, who has stepped down.

Bringing 20 years of experience in global technology and telecommunications, Mr Kolln is well-versed in Appen’s business and the AI industry.

Appen Chair Richard Freudenstein expressed the Board’s enthusiasm for Mr Kolln’s appointment.

“He has a deep understanding of Appen’s history, a strong technical understanding of the AI market, and a proven strategy background,” he said.

“This unique combination is ideal to guide Appen through its next phase and navigate the evolving generative AI market.”

Mr Kolln joined Appen AI in 2018 as VP of Corporate Development, playing a pivotal role in strategic acquisitions and contributed to the establishment of the China and Federal divisions.

His journey within Appen saw him take on the role of Chief Operating Officer in 2023, where he oversaw global operations and strategy.

Mr Kolln will continue to be based in North America.

APX shares were down 1.79 per cent, trading at 27.5 cents at 1:51 pm AEDT.

apx by the numbers
More From The Market Online

Green Technology Metals completes recapitalisation to fund Seymour pathway to FID

Green Technology Metals has successfully raised $11 million towards further funding of the Seymour lithium project…

Au King Mining signs contractors for Tundulu rare earths drilling

AuKing Mining has signed a drilling services contract ahead of a proposed drilling program at Tundulu…
The Market Online Video

FDA greenlights Syntara’s Amsulostat Phase 2b, setting up big 2026 catalysts

Syntara has had a positive outcome from its in person Type C meeting with the US…

Waratah Minerals obtains second 200 gram per metre intercept at Consols

Waratah Minerals has expanded the newly discovered Consols zone in results received from an ongoing drill…